Gilda Bontempo

Statistics

Publications

Citations

239

H-Index

Active since

2022

Affiliations

ViiV Healthcare (United Kingdom)(Current)

GlaxoSmithKline (United States)

Janssen (United States)

MUC Research (Germany)

Centre Hospitalier Universitaire de Bordeaux

Gilda Bontempo is an author at ViiV Healthcare (United Kingdom) specializing in antiviral pharmacotherapy, antiretroviral therapy, and clinical pharmacology.

Publications per year

2022–2024

Publications

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial

Josep M. Llibre, Carlos Brites, Chien‐Yu Cheng et al. · Clinical Infectious Diseases · 2022 · 170 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15

Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the <i>vastus lateralis</i> (lateral thigh) muscles of healthy adult participants

Kelong Han, Hakop Gevorkyan, Jafar Sadik Shaik et al. · Antimicrobial Agents and Chemotherapy · 2023 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings

Celia Jonsson‐Oldenbüttel, Jade Ghosn, Marc van der Valk et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2024 · 17 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +15

1584. CARISEL A Hybrid III Implementation Effectiveness Study of implementation of Cabotegravir plus Rilpivirine Long Acting (CAB+RPV LA) in EU Health Care Settings Key Clinical and Implementation Outcomes by Implementation Arm

Stéphane De Wit, Agathe Rami, Fabrice Bonnet et al. · Open Forum Infectious Diseases · 2022 · 11 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17

Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations

Cassidy A. Gutner, Laurent Hocqueloux, Celia Jonsson‐Oldenbüttel et al. · Journal of the International AIDS Society · 2024 · 11 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17

1–5 of 6